The 2022 WHO classification reflects increases in the knowledge of the underlying
pathogenesis of parathyroid disease. In addition to the classic characteristic features of …

Incidentally detected hypercalcemia usually presents in an indolent manner and is most
likely caused by primary hyperparathyroidism. In contrast, hypercalcemia in the patient with …

Objective: The surgical management of primary hyperparathyroidism (PHPT) has undergone
considerable advances over the past two decades. The purpose of this report is to review …

Opinion statement Parathyroid carcinoma is one of the rarest known malignancies that may
occur sporadically or as a part of a genetic syndrome. It accounts for approximately 1% of …

Parathyroid carcinoma (PC) is a rare endocrine malignancy, accounting for< 1% of all cases
of sporadic primary hyperparathyroidism (PHPT) and up to 15% in the hereditary …

Introduction Parathyroid carcinoma (PC) is a rare endocrine disorder, commonly causing
severe primary hyperparathyroidism (PHPT). PC is mainly a sporadic disease, but it may …

Simple Summary Parathyroid carcinoma (PC) is a rare endocrine malignancy and an
uncommon cause of primary hyperparathyroidism. It is more common in older Caucasians …

Parathyroid carcinoma (PC) is a rare disease with an indolent behavior due to the low
malignant potential. The etiology is unknown. Somatic mutations of CDC73 gene, the same …

Background Parathyroid carcinoma is a rare disease. Conflicting results on prognostic
factors and extent of surgical resection for patients with parathyroid carcinoma have been …

Proliferative pathologic lesions of parathyroid glands encompass a spectrum of entities
ranging from benign hyperplastic processes to malignant neoplasia. This review article …